District of Massachusetts | Drugmaker Nostrum and CEO Agree …
https://www.justice.gov/usao-ma/pr/drugmaker-nostrum-and-ceo-agree-pay-50-million-resolve-claims-underpaying-rebates-owed
WEBOct 30, 2023 · BOSTON – Nostrum Laboratories, Inc. (Nostrum), located in Missouri and New Jersey, and its founder and CEO Nirmal Mulye, Ph.D. (Mulye), have agreed to pay a minimum of $3,825,000 and up to $50 million if certain financial contingencies are met, to resolve allegations that they violated the False Claims Act by knowingly underpaying …
DA: 95 PA: 62 MOZ Rank: 69